SMO ClinPlus CO.,LTD. (SHE:301257)
China · Delayed Price · Currency is CNY 33.77
+1.05 (3.21%)
At close: Oct 30, 2026
SMO ClinPlus CO.,LTD. Market Cap
SMO ClinPlus CO.,LTD. has a market cap or net worth of 2.67 billion as of October 30, 2026. It is the 15,887th most valuable company in the world and the 4,244th biggest in China. Its market cap has decreased by 35.33% in one year.
Market Cap
2.67B
Enterprise Value
2.12B
Revenue
819.71M
Global Rank
Country Rank
#4,244 China
PE Ratio
93.42
ChartMarket Cap Chart
Since May 17, 2022, SMO ClinPlus CO.,LTD.'s market cap has decreased from 4.48B to 2.67B, a decrease of -40.43%. That is a compound annual growth rate of -10.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 2.67B | -35.11% |
| Dec 31, 2025 | 4.11B | 91.80% |
| Dec 31, 2024 | 2.14B | -44.81% |
| Dec 29, 2023 | 3.88B | 32.91% |
| Dec 30, 2022 | 2.92B | -34.76% |
| May 17, 2022 | 4.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 7.27B |
| Shanghai Runda Medical Technology | 5.54B |
| Maccura Biotechnology Co.Ltd | 5.43B |
| Cowealth Medical China | 4.19B |
| Shanghai Labway Clinical Laboratory | 4.04B |
| Thalys Medical Technology Group | 3.68B |
| Medicalsystem Biotechnology | 3.65B |
| Guangdong Hybribio Biotech | 3.60B |